Topic profile page for takeda pharmaceuticals.
This page has aggregated data from forum posts, threads, listings, online discussions, newsgroups, messageboards, and other online sources which contain user generated content for the term: takeda pharmaceuticals.
Started 14 hours, 40 minutes ago (2008-11-18 17:30:46)
by HobGlobulin
NTMD-Archemix Merger [This combination may answer the question: Is there life after BiDil?] http://www.businesswire.com/portal/site/biospace/i ndex.jsp?ndmViewId=news_view&newsId=2008111800 6487&newsLang=en > > NitroMed and Archemix Announce Merger Agreement Merger Part of NTMD Plan to Maximize Shareholder Value Conference Call and Webcast Scheduled for November 18, 2008 at 5:30 pm ET LEXINGTON, ...
Started 1 day, 19 hours ago (2008-11-17 12:45:00)
by AMLN55
Recs: 9 AP Amylin shares rise on prescription boost AP Amylin shares rise on Byetta prescriptions boost Monday November 17, 12:36 pm ET Amylin Pharmaceuticals shares gain ground as Byetta prescriptions rise in early November NEW YORK (AP) -- Shares of biotechnology company Amylin ...
Started 2 days, 14 hours ago (2008-11-16 17:24:00)
by whatever111
Recs: 4 Amylin Builds on the Success of Byetta Minor Label Changes and Approval of Once Weekly Version of Drug Are Anticipated Querida Anderson Nov 15 2008 (Vol. 28, No. 20) http://www.genengnews.com/articles/chitem.aspx?aid =2679 Amylin's scientists are primarily focused on investigating the potential utility of new peptide hormone candidates. The ...
Started 4 days, 18 hours ago (2008-11-14 13:32:00)
by warsurplus
Recs: 16 GEN: "Amylin Builds on the Success of Byetta" GEN (Genetic Engineering & biotechnology News): Nov 15 2008 (Vol. 28, No. 20) Amylin Builds on the Success of Byetta Minor Label Changes and Approval of Once Weekly Version of Drug Are Anticipated Querida Anderson The increasing incidence of obesity has ...
Started 5 days, 11 hours ago (2008-11-13 21:08:00)
by klip
Recs: 3 Re: News: ALNY pushes back Pedo Study and confirms...(Full article) [November 13, 2008] By Doug Macron Alnylam Pharmaceuticals has pushed back by at least six months the expected start of a phase II study of its respiratory syncytial virus treatment ALN-RSV01 in young children in order to wait for data from a separate trial of the drug in adult patients, ...
Started 5 days, 14 hours ago (2008-11-13 17:34:00)
by HobGlobulin
Recs: 4 Re: Alnylam Threw Us a Bone!!! >> Alnylam Pushes Back Pediatric Trial of RSV Drug to Wait for Adult-Trial Data [November 13, 2008] Alnylam Pushes Back Pediatric Trial of RSV Drug to Wait for Adult-Trial Data Alnylam Pharmaceuticals has pushed back by at least six months the expected start of a phase II study of its respiratory syncytial virus treatment ...
Started 5 days, 14 hours ago (2008-11-13 17:17:00)
by 330d
NEW ORLEANS The controversial diabetes pill Avandia failed to significantly slow plaque buildup in heart arteries compared with an older drug, though there were some hopeful signs in a new study reported Wednesday. Avandia, once a blockbuster drug made by British-based GlaxoSmithKline PLC, has been under a cloud since May 2007, when a medical journal report suggested it may raise the ...
Started 1 week, 3 days ago (2008-11-08 12:43:00)
by ki
CAMBRIDGE, Mass. & CARLSBAD, Calif., Nov 06, 2008 (BUSINESS WIRE) -- Regulus Therapeutics LLC, a joint venture between Alnylam Pharmaceuticals, Inc. (ALNY, Trade) and Isis Pharmaceuticals, Inc. (ISIS, Trade) formed to discover, develop, and commercialize microRNA-based therapeutics, announced today the publication of new research findings in the journal Cancer Cell demonstrating a ...
Started 1 week, 5 days ago (2008-11-06 12:23:00)
by bladerunner1717
(from BusinessWeek) Merger Mania In the past three years, large pharmaceutical companies have responded by merging, forming alliances, buying biotech companies, litigating against generic competitors, and cutting costs. Recent acquisition activity has been focused on smaller biotech firms with promising R&D profiles. S&P believes these responses could help mitigate some of the effects...
Started 1 week, 5 days ago (2008-11-06 08:44:00)
by jessme
Interesting article Vgoat. As usual Peregrine bucks the trend. Maybe BP doesn't think our pipeline is so promising? How long has VEA been collecting dust? VTA ocular? Heart conditions? The list goes on. Merger Mania In the past three years, large pharmaceutical companies have responded by merging, forming alliances, buying biotech companies , litigating against generic competitors, ...
